Pradaxa Maker Denied JMOL, New Trial In $1.7M Bleeding Injury Trial
HUNTINGDON, W.Va. — A West Virginia federal judge on May 15 denied judgment as a matter of law (JMOL) or a new trial to drug maker Boehringer Ingelheim Pharmaceuticals Inc. in...To view the full article, register now.
Already a subscriber? Click here to view full article